DQWS · XBRL financial data
DSwiss financial statements, every fiscal year
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (DQWS's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 1,348 | 1,959 | 1,849 | 1,470 | 3,113 | 2,921 |
| Cost of revenue | 980 | 1,460 | 1,404 | 1,111 | 2,490 | 2,356 |
| Gross profit | 367 | 499 | 445 | 359 | 623 | 565 |
| Selling, general and administrative | 288 | 309 | 402 | 368 | 604 | 631 |
| Other operating income (expense) | — | — | — | 7 | 13 | 40 |
| Operating income (loss) | (1) | (1) | (1) | (1) | (1) | (1) |
| Income tax expense (benefit) | 3 | 0 | 1 | 1 | 8 | 16 |
| Net income (loss) | 27 | 150 | (3) | (50) | 22 | (77) |
| Earnings per share, basic USD per share | — | 0.00 | (0.00) | (0.00) | 0.00 | (0.00) |
| Earnings per share, diluted USD per share | — | — | (0.00) | (0.00) | 0.00 | (0.00) |
| Weighted average shares, basic thousands of shares | — | 206,905 | 206,905 | 206,905 | 206,905 | 206,905 |
| Weighted average shares, diluted thousands of shares | — | — | 206,905 | 206,905 | 206,905 | 206,905 |
Balance sheet
CSVFiscal years (DQWS's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 158 | 235 | 214 | 249 | 397 | 285 |
| Accounts receivable | 9 | 2 | 17 | 36 | 75 | 17 |
| Inventory | 38 | 17 | 7 | 7 | 3 | 2 |
| Prepaid and other current assets | 34 | 54 | 22 | 25 | 22 | 27 |
| Total current assets | 239 | 308 | 262 | 317 | 498 | 332 |
| Property and equipment, net | 52 | 93 | 72 | 48 | 137 | 189 |
| Right-of-use asset | 48 | 93 | 45 | — | — | 156 |
| Total assets | 344 | 498 | 382 | 367 | 636 | 677 |
| Accounts payable | 1 | 11 | 30 | 99 | 153 | 113 |
| Total current liabilities | 382 | 319 | 245 | 295 | 484 | 465 |
| Lease liability, non-current | — | 47 | — | — | — | 129 |
| Total liabilities | 414 | 424 | 284 | 311 | 562 | 686 |
| Accumulated deficit | (1,483) | (1,310) | (1,324) | (1,410) | (1,388) | (1,465) |
| Total stockholders' equity | (95) | 73 | 86 | 56 | 74 | (9) |
| Total liabilities and equity | 344 | 498 | 382 | 367 | 636 | 677 |
| Common shares outstanding (cover page) thousands of shares | 206,905 | 206,905 | 206,905 | 206,905 | 206,905 | 206,905 |
Cash flows
CSVFiscal years (DQWS's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | 27 | 150 | (3) | (50) | 22 | (77) |
| Depreciation and amortization | 66 | 20 | 72 | 65 | — | — |
| Net cash from operating activities | 59 | 252 | 22 | 45 | 183 | (94) |
| Purchases of property and equipment | 2 | 62 | 14 | 0 | 106 | 41 |
| Net cash from investing activities | (2) | (62) | (14) | (0) | (105) | (8) |
| Net cash from financing activities | 105 | (79) | (54) | (16) | 68 | (35) |
| Net change in cash | 110 | 77 | (20) | 35 | 148 | (112) |
Compare with peers
SIC 2844 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 2844 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| DSwiss | 258 | 512 | 50* | 206.9M | — | 10-QJun 30, 2026 |
| Longevity Health Holdings | 35 | 396 | (224)* | 2.5M | 0.2 quarters | 10-QJun 30, 2026 |
| Karbon-X | 335 | 344 | (1,198) | 109.2M | — | 10-Q/AAug 31, 2026 |
| Bonk | 214 | 793 | (2,226)* | 8.0M | 0.1 quarters | 10-QJun 30, 2026 |
| Scientist Home Future Health | 14 | 212 | (45)* | 23.7M | — | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.